Customizable anchorage devices and methods of use

Patent metadata

Field	Value
Publication number	US-10939901-B2
Application number	US-201715583153-A
Country	US
Kind code	B2
Filing date	May 1, 2017
Priority date	May 4, 2016
Publication date	Mar 9, 2021
Grant date	Mar 9, 2021

Abstract

An anchorage device includes a substrate extending along a longitudinal axis between a first end having a first bonding area and an opposite second end having a second bonding area. The substrate has a third bonding area between the first and second bonding areas. Kits, systems and methods are disclosed.

First claim

What is claimed is:

1. A surgical system comprising:
an implantable medical device; and
a customizable anchorage device configured for anchoring the implantable medical device within a patient's body, the anchorage device comprising:
a substrate extending along a longitudinal axis between a first end comprising a first bonding area and an opposite second end comprising a second bonding area that is spaced apart from the first bonding area by a first non-bonding area, the first bonding area defining a first portion of a perimeter of the substrate, the second bonding area defining an opposite second portion of the perimeter, the substrate comprising a third bonding area between the first and second bonding areas, the third bonding area being spaced apart from the second bonding area by a second non-binding area, the non-bonding areas including a first composition, the bonding areas including a second composition that is different than the first composition,
wherein a hemostatic agent is applied to the substrate via a polymer, the polymer comprising an antibiotic and the hemostatic agent, the polymer being configured to elute the antibiotic and the hemostatic agent as the polymer degrades, and
wherein the substrate is configured to be folded along the longitudinal axis such that first portions of the bonding areas engage second portions of the bonding areas.

2. The surgical system recited in claim 1 , wherein the bonding areas each include an adhesive and a nonstick material that covers the adhesive.

3. The surgical system recited in claim 1 , wherein:
the bonding areas each include an adhesive and a removable nonstick material that covers the adhesive;
first sections of the adhesives of the first and second bonding areas engage second sections of the adhesives of the first and second bonding areas when the first portions of the first and second bonding areas engage the second portions of the first and second bonding areas; and
a first section of the nonstick material of the third bonding area engages a second section of the nonstick material of the third bonding area when the first portion of the third bonding area engages the second portion of the third bonding area.

4. The surgical system recited in claim 1 , wherein:
the bonding areas each include an adhesive and a removable nonstick material that covers the adhesive;
first sections of the adhesives of the first and third bonding areas engage second sections of the adhesives of the first and third bonding areas when the first portions of the first and third bonding areas engage the second portions of the first and third bonding areas; and
a first section of the nonstick material of the second bonding area engages a second section of the nonstick material of the second bonding area when the first portion of the second bonding area engages the second portion of the second bonding area.

5. The surgical system recited in claim 1 , wherein the hemostatic agent comprises tranexamic acid.

6. The surgical system recited in claim 1 , wherein the substrate is a mesh substrate.

7. The surgical system recited in claim 1 , wherein the antibiotic is selected from a group consisting of rifampin and minocycline and mixtures thereof.

8. The surgical system recited in claim 1 , wherein the polymer is a polyarylate.

9. The surgical system recited in claim 1 , wherein the polymer is member of the P22-xx family.

10. A surgical system comprising:
an implantable medical device; and
a customizable anchorage device configured for anchoring the implantable medical device within a patient's body, the anchorage device comprising:
a substrate extending along a longitudinal axis between a first end comprising a first bonding area and an opposite second end comprising a second bonding area that is spaced apart from the first bonding area by a first non-bonding area, the first bonding area defining a first portion of a perimeter of the substrate, the second bonding area defining an opposite second portion of the perimeter, the substrate comprising a plurality of spaced apart bonding areas between the first and second bonding areas, the plurality of spaced apart bonding areas each being spaced apart from the first bonding area and the second bonding area by a second non-bonding area, the non-bonding areas including a first composition, the bonding areas including a second composition that is different than the first composition, wherein a hemostatic agent is applied to the non-bonding areas via a polymer, the polymer comprising an antibiotic and the hemostatic agent, the polymer being configured to elute the antibiotic and the hemostatic agent as the polymer degrades.

11. The surgical system recited in claim 10 , wherein the plurality of spaced apart bonding areas comprises third and fourth bonding areas.

12. The surgical system recited in claim 10 , wherein the substrate is configured to be folded along the longitudinal axis such that first portions of the bonding areas engages second portions of the bonding areas.

13. The surgical system recited in claim 10 , wherein the bonding areas each include an adhesive and a nonstick material that covers the adhesive.

14. The surgical system recited in claim 10 , wherein:
the bonding areas each include an adhesive and a removable nonstick material that covers the adhesive;
first sections of the adhesives of the first and second bonding areas engage second sections of the adhesives of the first and second bonding areas when the first portions of the first and second bonding areas engage the second portions of the first and second bonding areas; and
first sections of the nonstick materials of the third and fourth bonding areas engage second sections of the nonstick materials of the third and fourth bonding areas when the first portions of the third and fourth bonding areas engage the second portions of the third and fourth bonding areas.

15. The surgical system recited in claim 10 , wherein:
the bonding areas each include an adhesive and a removable nonstick material that covers the adhesive;
first sections of the adhesives of the first and third bonding areas engage second sections of the adhesives of the first and third bonding areas when the first portions of the first and third bonding areas engage the second portions of the first and third bonding areas; and
first sections of the nonstick materials of the second and fourth bonding areas engage second sections of the nonstick materials of the second and fourth bonding areas when the first portions of the second and fourth bonding areas engage the second portions of the second and fourth bonding areas.

16. A method of customizing an anchorage device comprising:
providing an anchorage device comprising a substrate extending along a longitudinal axis between a first end comprising a first bonding area and an opposite second end comprising a second bonding area that is spaced apart from the first bonding area by a first non-bonding area, the substrate comprising a plurality of spaced apart bonding areas between the first and second bonding areas, the plurality of spaced apart bonding areas each being spaced apart from the first bonding area and the second bonding area by a second non-bonding area, the non-bonding areas including a first composition, the bonding areas including a second composition that is different than the first composition, wherein a hemostatic agent is applied to at least a portion of the substrate via a polymer, the polymer comprising an antibiotic and the hemostatic agent, the polymer the antibiotic and the hemostatic agent as the polymer degrades, a

Assignees

• Tyrx Inc
• Medtronic Inc

Inventors

• Pulapura Satish
• Buevich Fatima
• Rajaram Archana
• Mahoney Jonathan M
• Le Dan Thanh

Classifications

• A61L31/04 Primary

  Macromolecular materials · CPC title

• A61L31/16

  Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

• A61L31/148

  Materials at least partially resorbable by the body · CPC title

• A61L31/146

  Porous materials, e.g. foams or sponges · CPC title

• A61L31/10

  Macromolecular materials · CPC title